Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-20
2009-10-13
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S180000
Reexamination Certificate
active
07601741
ABSTRACT:
The reaction of methylmagnesium halide is improved by the presence of a cerium (III) salt such as cerium trichloride. The reactions are typically associated with the production of montelukast, a pharmaceutically useful compound of the following formulaand salts thereof. Further enhancements can be derived from certain intermediates, salts thereof and/or purification thereof before and/or after the reaction involving methylmagnesium halide.
REFERENCES:
patent: 4999362 (1991-03-01), Gandolfi et al.
patent: 5266568 (1993-11-01), Belley et al.
patent: 5270324 (1993-12-01), Zamboni et al.
patent: 5523477 (1996-06-01), King et al.
patent: 5565473 (1996-10-01), Belley et al.
patent: 5585115 (1996-12-01), Sherwood et al.
patent: 5614632 (1997-03-01), Bhupathy et al.
patent: 5856322 (1999-01-01), Belley et al.
patent: 5869673 (1999-02-01), Tung et al.
patent: 6063802 (2000-05-01), Winterborn
patent: 6320052 (2001-11-01), Bhupathy et al.
patent: 2004/0265375 (2004-12-01), Platteeuw et al.
patent: 2005/0107426 (2005-05-01), Overeem et al.
patent: 2005/0245568 (2005-11-01), Overeem et al.
patent: 2005/0245569 (2005-11-01), Overeem et al.
patent: 2007/0135480 (2007-06-01), Benovsky et al.
patent: 2007/0135642 (2007-06-01), Benovsky et al.
patent: 1420113 (2003-05-01), None
patent: 0 480 717 (1992-04-01), None
patent: WO 95/18107 (1995-07-01), None
March, J. Advanced Organic Chemistry 4th Ed., 1992., pp. 323, 357.
Alfa Aesar Chemical Catalog, A Johnson Matthey Co. 2006-2007, pp. 1414.
Carey, F.A.: Sundberg, R. J. Advanced Organic Chemistry, 4thEdition, Part A, Kluwer Academic/Plenum Publishers, pp. 204-215.
“An Efficient Synthesis of LTD4Antagonist L-699,392” by A.O. King et al.,J. Org. Chem. 1993, 58, pp. 3731-3735.
Organic Synthesis, Coll. vol. 10, p. 200 (2004); vol. 76, p. 228 (1999).
Bartos Petr
Benovsky Petr
Castulik Jakub
Overeem Arjanne
Skoumal Radomir
Buscher Mark R.
Desai Rita J
Mabry John
Synthon BV
LandOfFree
Process for making montelukast and intermediates therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for making montelukast and intermediates therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for making montelukast and intermediates therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083012